RedHill Biopharma (RDHL) Return on Sales [ROS] (2012 - 2023)
RedHill Biopharma (RDHL) posted Return on Sales [ROS] of -2776.92% for the year ended Dec 31, 2025, down 2696.42 percentage points from -80.50% a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Return on Sales [ROS] (2012 - 2023) Analysis & Trends
Since the year ended Dec 31, 2011, RedHill Biopharma has reported Return on Sales [ROS] for 15 years.
- Annual Return on Sales [ROS] shows a five-year change of -2875.87 percentage points (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 stands as the lowest annual Return on Sales [ROS] in data going back to the year ended Dec 31, 2011.
- Business Quant data shows RDHL's Return on Sales [ROS] at -80.50% in the year ended Dec 31, 2024 (+65.71 pp), -146.22% in the year ended Dec 31, 2023 (-76.89 pp), -69.33% in the year ended Dec 31, 2022 (+25.28 pp) and -94.61% in the year ended Dec 31, 2021 (-193.56 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | RedHill Biopharma | 7.38 Mn | 7.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 2,992.87% |
| Mar 31, 2023 | -808.00% |
| Dec 31, 2022 | -591.81% |
| Sep 30, 2022 | 40.50% |
| Jun 30, 2022 | 49.92% |
| Mar 31, 2022 | 126.90% |
| Dec 31, 2021 | -641.43% |
| Sep 30, 2021 | 80.51% |
| Jun 30, 2021 | 115.74% |
| Mar 31, 2021 | 88.22% |
| Dec 31, 2020 | 91.83% |
| Sep 30, 2020 | 69.04% |
| Jun 30, 2020 | 59.81% |
| Mar 31, 2020 | 1,611.36% |
| Dec 31, 2019 | 739.87% |
| Sep 30, 2019 | 702.64% |
| Jun 30, 2019 | 792.07% |
| Mar 31, 2019 | 530.40% |
| Dec 31, 2018 | 739.00% |
| Sep 30, 2018 | 441.34% |
API Access
RedHill Biopharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();